Products for Research Use Only
RegisterLogin

Palazestrant

CAT: 1568-C01903-25mgSize: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1568-C01903-25mgSize:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.

Alternative Products

CatalogName
MBS5815186Palazestrant

Popular Products